The department of Science and Technology has a budget estimate of ₹28,049.32 crore for 2026–27, with a notable ₹20,000 crore ...

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

The Union Budget 2026–27 underscores India’s commitment to building a robust healthcare and education ecosystem, with major investments in medical, pharmaceutical, and allied health training.

Traditional systems of medicine and mental health education have also received attention with the government proposing three ...

Will Budget 2026’s ₹10,000 crore Biopharma Shakti plan transform India into a global biopharma manufacturing hub? Read report ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

The Lehigh Valley plant will be Indianapolis-based Lilly’s first manufacturing facility in Pennsylvania. Construction is ...

In the run-up to the Union Budget 2026 presentation, healthcare leaders are urging a push toward technology-driven medical ...

Amid the surging wave of innovation in China's biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector-from its initial emergence and growth to fundamental ...

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.